Skip to main content
NCBI home page
Frontiers in Immunology logoLink to Frontiers in Immunology
. 2026 Aug 14;17:1933966. doi: 10.3389/fimmu.2026.1933966

Correction: C3a receptor signaling inhibits neurodegeneration induced by neonatal hypoxic-ischemic brain injury

Andrea Pozo-Rodrigálvarez 1, YiXian Li 1,†, Anna Stokowska 1,†, Jingyun Wu 1,2, Verena Dehm 1, Hana Sourkova 2, Harry Steinbusch 3,4, Carina Mallard 5, Henrik Hagberg 5,6, Milos Pekny 2, Marcela Pekna 1,*
PMCID: PMC13522813  PMID: 42666426

There was a mistake in Figure 5 as published. When resizing the two representative images of GFAP immunoreactivity in C, the image for C3a treatment was accidentally dropped on part of the image for PBS treatment. The corrected Figure 5 appears below.

Figure 5.

Figure 5

Open in a new tab

The original version of this article has been updated.

Footnotes

Edited and reviewed by: Zhi-Qing David Xu, Capital Medical University, China

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Articles from Frontiers in Immunology are provided here courtesy of Frontiers Media SA

RESOURCES